Spectral Historical Financial Ratios
| EDT Stock | CAD 0.56 0.03 5.66% |
Spectral Med is promptly reporting on over 94 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 40.36 or Invested Capital of 0.0 will help investors to properly organize and evaluate Spectral Med financial condition quickly.
Spectral |
About Spectral Financial Ratios Analysis
Spectral MedFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Spectral Med investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Spectral financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Spectral Med history.
Spectral Med Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Spectral Med stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Spectral Med sales, a figure that is much harder to manipulate than other Spectral Med multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Dividend Yield
Dividend Yield is Spectral Med dividend as a percentage of Spectral Med stock price. Spectral Med dividend yield is a measure of Spectral Med stock productivity, which can be interpreted as interest rate earned on an Spectral Med investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.Free Cash Flow Yield
A financial solvency ratio that compares the free cash flow per share a company is expected to earn against its market value per share, calculated as free cash flow per share divided by market price per share.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Tangible Asset Value
The total value of a company's physical, tangible assets, excluding intangible assets like patents and trademarks.Most ratios from Spectral Med's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Spectral Med current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Spectral Med. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Spectral Med's Income Quality is very stable compared to the past year. As of the 2nd of December 2024, ROE is likely to grow to 0.99, while Price To Sales Ratio is likely to drop 45.68.
| 2021 | 2022 | 2023 (projected) | Payables Turnover | 1.87 | 0.41 | 0.59 | Days Of Inventory On Hand | 128.54 | 181.43 | 142.72 |
Spectral Med fundamentals Correlations
Click cells to compare fundamentals
Spectral Med Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Spectral Med fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 56.67 | 44.82 | 27.07 | 59.89 | 74.09 | 45.68 | |
| Ptb Ratio | 71.91 | (140.75) | 13.6 | (39.57) | (7.15) | (6.8) | |
| Days Sales Outstanding | 100.54 | 45.17 | 36.46 | 231.22 | 42.48 | 40.36 | |
| Book Value Per Share | 0.01 | (0.002877) | 0.0162 | (0.00935) | (0.0594) | (0.0564) | |
| Free Cash Flow Yield | (0.0178) | (0.006786) | (0.17) | (0.0998) | (0.0921) | (0.0967) | |
| Operating Cash Flow Per Share | (0.0121) | (0.001394) | (0.0345) | (0.0368) | (0.0385) | (0.0404) | |
| Stock Based Compensation To Revenue | 0.22 | 0.42 | 0.61 | 0.72 | 0.93 | 0.98 | |
| Capex To Depreciation | 0.58 | 1.04 | 1.64 | 0.12 | 0.85 | 1.22 | |
| Pb Ratio | 71.91 | (140.75) | 13.6 | (39.57) | (7.15) | (6.8) | |
| Ev To Sales | 56.43 | 42.37 | 23.02 | 58.83 | 77.6 | 81.48 | |
| Free Cash Flow Per Share | (0.0128) | (0.002748) | (0.0364) | (0.0369) | (0.0392) | (0.0411) | |
| Roic | (0.34) | (2.09) | 13.41 | (10.66) | 1.33 | 1.39 | |
| Inventory Turnover | 2.36 | 1.8 | 2.84 | 2.01 | 2.56 | 2.43 | |
| Net Income Per Share | (0.0216) | (0.0386) | (0.0345) | (0.0419) | (0.0562) | (0.059) | |
| Days Of Inventory On Hand | 154.98 | 202.26 | 128.54 | 181.43 | 142.72 | 165.55 | |
| Payables Turnover | 1.85 | 2.18 | 0.54 | 1.87 | 0.41 | 0.59 | |
| Sales General And Administrative To Revenue | 2.34 | 4.81 | 4.6 | 4.8 | 6.88 | 7.22 | |
| Capex To Revenue | 0.0561 | 0.15 | 0.24 | 0.0198 | 0.12 | 0.11 | |
| Cash Per Share | 0.006641 | 0.026 | 0.0381 | 0.0321 | 0.0128 | 0.0121 | |
| Pocfratio | (59.36) | (290.63) | (6.38) | (10.06) | (11.04) | (11.59) | |
| Interest Coverage | (130.83) | (284.03) | (307.18) | (90.77) | (8.56) | (8.99) | |
| Capex To Operating Cash Flow | (0.0588) | (0.97) | (0.0555) | (0.003324) | (0.0173) | (0.0181) | |
| Pfcf Ratio | (56.06) | (147.36) | (6.05) | (10.02) | (10.86) | (11.4) | |
| Days Payables Outstanding | 167.34 | 674.79 | 194.78 | 880.48 | 622.37 | 313.9 | |
| Income Quality | 0.56 | 0.0356 | 0.99 | 0.88 | 0.68 | 0.84 | |
| Roe | (2.15) | 13.43 | (2.14) | 4.48 | 0.95 | 0.99 | |
| Ev To Operating Cash Flow | (59.11) | (274.76) | (5.43) | (9.88) | (11.57) | (12.14) | |
| Pe Ratio | (33.39) | (10.48) | (6.37) | (8.84) | (7.56) | (7.94) | |
| Return On Tangible Assets | (1.3) | (1.13) | (0.77) | (0.96) | (3.12) | (2.97) | |
| Ev To Free Cash Flow | (55.82) | (139.32) | (5.14) | (9.85) | (11.37) | (11.94) | |
| Earnings Yield | (0.03) | (0.0954) | (0.16) | (0.11) | (0.13) | (0.14) | |
| Intangibles To Total Assets | 0.0657 | 0.0301 | 0.0197 | 0.0176 | 0.037 | 0.0352 | |
| Net Debt To E B I T D A | 0.15 | 0.59 | 1.25 | 0.25 | (0.4) | (0.38) | |
| Current Ratio | 2.46 | 2.34 | 4.46 | 2.55 | 0.4 | 0.38 | |
| Tangible Book Value Per Share | 0.008847 | (0.003935) | 0.0153 | (0.0101) | (0.0601) | (0.0571) | |
| Receivables Turnover | 3.63 | 8.08 | 10.01 | 1.58 | 8.59 | 9.02 | |
| Graham Number | 0.0697 | 0.05 | 0.11 | 0.0939 | 0.27 | 0.26 | |
| Shareholders Equity Per Share | 0.01 | (0.002877) | 0.0162 | (0.00935) | (0.0594) | (0.0564) |
Pair Trading with Spectral Med
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Spectral Med position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spectral Med will appreciate offsetting losses from the drop in the long position's value.Moving against Spectral Stock
| 0.78 | NVDA | NVIDIA CDR | PairCorr |
| 0.74 | TD-PFD | Toronto Dominion Bank Earnings Call This Week | PairCorr |
| 0.72 | GOOG | Alphabet CDR | PairCorr |
| 0.72 | BOFA | Bank of America | PairCorr |
| 0.71 | AMZN | Amazon CDR | PairCorr |
The ability to find closely correlated positions to Spectral Med could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Spectral Med when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Spectral Med - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Spectral Med to buy it.
The correlation of Spectral Med is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Spectral Med moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Spectral Med moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Spectral Med can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Spectral Stock
Spectral MedFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Spectral Med investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Spectral financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Spectral Med history.